NEW YORK (GenomeWeb) – GenMark Diagnostics today reported a 34 percent increase year over year in its third quarter revenues, but the firm has moved back the European launch of its ePlex sample-to-answer system.

For the three months ended Sept. 30, GenMark's total revenues increased to $8.5 million from $ 6.3 million in the prior-year period. The firm beat the average Wall Street estimate of $8.2 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.